A. Labelle
Impact in
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Biological Psychiatry top 10%
Papers in
-
- Schizophrenia research and treatment 2
- Electroconvulsive Therapy Studies 1
-
- Treatment of Major Depression 1
- Co-authors
- B. Jones (2 shared papers)Donald Addington (1 shared paper)Guy Chouinard (1 shared paper)Gary Remington (1 shared paper)D. M. Bloom (1 shared paper)G. William MacEwan (1 shared paper)Linda Beauclair (1 shared paper)Wendy Arnott (1 shared paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
A. Labelle
3 papers receiving 731 citations
A. Labelle's Hit Papers
Peers
Comparison fields: 5 of 71
- Psychiatry and Mental health 623
- Biological Psychiatry 46
- Philosophy 181
- Pharmacology 130
- Cognitive Neuroscience 124
Countries citing papers authored by A. Labelle
This map shows the geographic impact of A. Labelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Labelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Labelle more than expected).
Fields of papers citing papers by A. Labelle
This network shows the impact of papers produced by A. Labelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Labelle. The network helps show where A. Labelle may publish in the future.
Co-authors
The 12 scholars most cited alongside A. Labelle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients Hit paper breakdown → | 1993 | 704 |
| 2 | 2001 | 76 | |
| 3 | 2000 | 5 |
About A. Labelle
A. Labelle is a scholar working on Psychiatry and Mental health, Pharmacology, Cognitive Neuroscience, Infectious Diseases and Organic Chemistry, having authored 3 papers that have together received 785 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (2 papers), Electroconvulsive Therapy Studies (1 paper), Functional Brain Connectivity Studies (1 paper), EEG and Brain-Computer Interfaces (1 paper), Neural dynamics and brain function (1 paper) and Treatment of Major Depression (1 paper). The work is most often cited by research in Psychiatry and Mental health (623 citations), Biological Psychiatry (46 citations), Philosophy (181 citations), Pharmacology (130 citations) and Cognitive Neuroscience (124 citations). A. Labelle has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include B. Jones, Donald Addington, Guy Chouinard, Gary Remington, D. M. Bloom, G. William MacEwan, Linda Beauclair, Wendy Arnott, Colleen Mahoney and Verner Knott. Their work appears in journals such as Schizophrenia Research and Journal of Clinical Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.